Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesExcess mortality, length of stay and cost attributable to candidaemia
Journal of Infection, 10/06/09
Hassan I et al. – Candidaemia remains a severe disease associated with high attributable mortality in the UK. In addition, candidaemia leads to additional ICU length of stay and costs. The implication is an attributable cost of at least £16.2 million with 683 deaths attributable to candidaemia per year in the UK.
Related Articles
Epidemiology, risk factors for and outcome of candidaemia among non-neutropenic patients in a Greek intensive care unit
Mycoses, 10/05/09
Relevance Score: 90%
Incidence and predictors of invasive candidiasis associated with candidaemia in children
Mycoses, 10/19/09
Relevance Score: 84%
Candida and the paediatric lung
Paediatric Respiratory Reviews, 11/06/09
Relevance Score: 77%
Today in Fungal Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study
Diagnostic Microbiology and Infectious Disease, 12/09/09
Recognition, Diagnosis, and Treatment of Histoplasmosis Complicating Tumor Necrosis Factor Blocker Therapy
Clinical Infectious Diseases, 12/08/09
Administration of IL-23 engages innate and adaptive immune mechanisms during fungal infection
International Immunology, 12/07/09
Article Search
Sponsor